AKAO-The text you excerpted has a notable omission: the statistical power of the trial. And there was no mention of statistical power in the PR. A review of the trial at clinicaltrials.gov has nothing to say about this as well. Does the listing of the protocol on clinicaltrials mean that the design has been signed off by the FDA?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.